Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

company_intel Aventis Pharmaceuticals Inc.


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$41
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Agreement of Sublease Ariad Pharma;
Aventis Pharma 		Law FirmMintz Levin;
Law FirmMorgan Lewis
$36
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Aventis Pharma;
Nastech 		Questcor Pharma
$31
 Subscribers Subscribers
Preview 		2004
 For Immediate Release Aventis Pharmaceuticals Inc. Questcor Pharmaceuticals Inc.
$36
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Aventis Pharmaceuticals Inc. Questcor Pharmaceuticals Inc.
$38
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Aventis Pharma;
Questcor Pharma 		Tularik
$36
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Aventis Pharma;
Questcor Pharma 		Tularik
$36
 Subscribers Subscribers
Preview 		2004
 For Immediate Release Aventis Pharmaceuticals Inc. Transkaryotic Therapies Inc.
$31
 Subscribers Subscribers
Preview 		2004
 KOS Announces Strategic Acquisition of Azmacort Franchise From Aventis Aventis Pharmaceuticals Inc. KOS Pharmaceuticals, Inc.
$73
 Subscribers Subscribers
2003
 ContractIntelligence Memorandum of Lease Aventis Pharma;
Wells REIT 		BankCitibank;
Law FirmMorgan Lewis
$37
 Subscribers Subscribers
2004
 News Release Aventis Pharma;
Genentech;
GlaxoSmithKline 		Millennium;
Harvard
$36
 Subscribers Subscribers
2004
 News Release Amgen;
Aventis Pharma;
Genentech 		TKT;
Tularik;
Wyeth
$47
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Option Agreement Aventis Pharma;
Sanofi 		ViroPharma
$51
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Option Agreement Aventis Pharma;
Sanofi 		ViroPharma
$38
 Subscribers Subscribers
Preview 		2004
 Press Release Aventis Pharma;
Novartis Pharma 		Regeneron Pharma;
Stanford
$38
 Subscribers Subscribers
Preview 		2004
 Press Release Aventis Pharma;
Novartis Pharma 		Regeneron Pharma
$32
 Subscribers Subscribers
2004
 Press Release Aventis Pharma;
ViroPharma 		Wyeth
$32
 Subscribers Subscribers
2003
 Press Release Aventis Pharma;
ViroPharma 		Wyeth
$99
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Restated P53 and K-RAS Agreement Rhone-Poulenc Rorer Pharmaceuticals Inc.;
Aventis Pharmaceuticals Products Inc.;
Aventis Pharma 		Aventis Pharma
Entity
Bank Law Firm 2
$36
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Sales Force Transfer Agreement Aventis Pharmaceuticals Inc. ViroPharma Inc.
$62
 Subscribers Subscribers
Preview 		2000
 ContractIntelligence Technology Transfer Agreement Aventis Pharmaceuticals Inc. Millennium Pharmaceuticals Inc.